|
HS Code |
369053 |
| Chemical Name | Lithocholic Acid |
| Cas Number | 434-13-9 |
| Molecular Formula | C24H40O3 |
| Molecular Weight | 376.57 g/mol |
| Appearance | White crystalline powder |
| Melting Point | 198-203°C |
| Solubility | Insoluble in water, soluble in ethanol and chloroform |
| Pka | 5.5 |
| Iupac Name | (3α)-3-hydroxy-5β-cholan-24-oic acid |
| Synonyms | LCA; Lithocholate |
| Boiling Point | Decomposes before boiling |
| Storage Conditions | Store at 2-8°C, tightly closed |
| Pubchem Cid | 64725 |
As an accredited Lithocholic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Lithocholic Acid is packaged in a 25g amber glass bottle with a tamper-evident cap and detailed safety labeling. |
| Shipping | Lithocholic Acid is shipped in tightly sealed containers, protected from light and moisture. It is typically packaged in accordance with hazardous material regulations, ensuring safe handling during transit. Labels indicating its chemical nature and safety precautions are affixed. Appropriate documentation accompanies the shipment for regulatory and safety compliance. |
| Storage | Lithocholic Acid should be stored in a tightly closed container, protected from light and moisture. Keep it in a cool, dry, and well-ventilated area, ideally at 2–8°C (refrigerated conditions). Avoid exposure to strong oxidizers and acids. Properly label the container and restrict access to trained personnel only. Follow all relevant safety and regulatory guidelines for chemical storage. |
|
Purity 98%: Lithocholic Acid with 98% purity is used in pharmaceutical research, where it ensures reproducibility and accurate bioactivity assessment. Melting Point 198°C: Lithocholic Acid at a melting point of 198°C is used in analytical standards, where it provides consistent thermal stability during qualitative assays. Molecular Weight 376.58 g/mol: Lithocholic Acid with a molecular weight of 376.58 g/mol is used in bile acid metabolism studies, where it enables precise molecular quantification. Particle Size <10 μm: Lithocholic Acid with a particle size less than 10 μm is used in formulation development, where it enhances compound dispersion in delivery systems. HPLC Grade: Lithocholic Acid of HPLC grade is used in chromatographic separation, where it guarantees high resolution and reliable analytical results. Stability Temperature up to 60°C: Lithocholic Acid stable up to 60°C is used in biochemical assays, where it maintains structural integrity under various operational conditions. Water Content <0.5%: Lithocholic Acid with water content below 0.5% is used in synthetic chemistry, where it reduces risk of hydrolytic degradation in reactions. Endotoxin Level <0.1 EU/mg: Lithocholic Acid with endotoxin level less than 0.1 EU/mg is used in cell culture experiments, where it minimizes cytotoxic interference. Solubility in DMSO ≥50 mg/mL: Lithocholic Acid with solubility in DMSO of at least 50 mg/mL is used in drug screening assays, where it facilitates preparation of high-concentration stock solutions. Optical Rotation +38° to +42°: Lithocholic Acid with optical rotation between +38° and +42° is used in stereoisomer analysis, where it aids in confirming enantiomeric purity. |
Competitive Lithocholic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Scientific progress often walks hand in hand with substances that seem subtle on paper but stir up waves in research and applied fields. Lithocholic acid stands as an example of such a molecule. Found naturally in human bile, this secondary bile acid takes shape when gut microbes break down primary bile acids, sculpting it into a compound with a unique set of properties.
Growing up in an era where the term “gut health” was only a chapter in thick medical textbooks, I rarely imagined the compounds churning quietly through our digestive systems would one day become topics at the heart of clinical studies, pharmaceutical research, and even new nutritional paradigms. Lithocholic acid entered the stage of scientific investigation as more than a byproduct of digestion. With each published study, curiosity about its physiological roles, therapeutic potential, and industrial applications picked up speed.
In research labs today, lithocholic acid often comes as a fine, off-white powder, carefully sealed and labeled to protect it from moisture and light. Chemically, its formula—C24H40O3—expresses a backbone familiar to anyone who’s studied steroids. Yet, the mild bitterness on the tongue and distinctive musty odor set it apart from other compounds you might find on a scientist’s shelf. Material safety data reports regularly point out that it melts around 197-198 degrees Celsius, though you’ll rarely catch it bubbling away unless someone is running a cluster of chromatographic tests late into the evening.
Purity matters in the buying decision for any laboratory—pharmaceutical standards often ask for levels above 98 percent, sometimes up to 99.5 percent for clinical or investigational work. In contrast, lower purities find their way into industrial research or chemical synthesis, where minor impurities don’t tip the scale. Manufacturers use high-grade analytical techniques like HPLC to guarantee content accuracy. Over the years, I’ve observed that even a quarter percent difference in purity can mean the difference between reproducible data and hours spent retracing experimental steps.
You might hear about other bile acids landing on the same shelf—cholic acid, deoxycholic acid, chenodeoxycholic acid, and ursodeoxycholic acid. These siblings in the bile acid family share a four-ring steroid structure, yet differences in their hydroxyl group positions create distinct biochemical paths in the body and distinct uses in the lab. While cholic and chenodeoxycholic acids star in bile acid replacement therapies and gallstone dissolution, lithocholic acid carves a unique niche. Its hydrophobicity—scientists refer to its low water solubility—affects its impact on cell membranes, gut flora, and more.
From what I’ve gathered attending seminars and reading through journals, lithocholic acid’s uniqueness springs from its biological activity profile. Unlike its relatives, this acid tends toward cytotoxic and even pro-oxidant behaviors at higher concentrations. Early studies warned about its damaging potential to liver cells when the body fails to eliminate it efficiently. Yet the story took a fascinating turn when researchers found pathways where lithocholic acid—when finely dosed and correctly managed—affects cellular signaling, apoptosis, and even aging.
I remember a colleague quoting a study from a major university: by exposing yeast cells to lithocholic acid, researchers extended the organisms’ lifespan. The same molecule researchers once blamed for liver toxicity became a potential anti-aging tool in cell biology. This duality, both as a caution and a promise, gives lithocholic acid an edge over more domesticated bile acids.
Pharmaceutical scientists didn’t overlook lithocholic acid’s riddle. On one hand, its cytotoxic tendencies have triggered interest in developing drugs to target certain cancer cell lines. Tumor cells, with their unique metabolic quirks, sometimes falter in the presence of lithocholic acid while normal cells remain relatively unscathed under controlled conditions. Ongoing studies look at its role in apoptosis pathways—how it may prompt programmed cell death, a holy grail in cancer research.
Clinical researchers are steadily mapping out how lithocholic acid interacts with the gut microbiome, immune function, and metabolic health. Some experiments raise the prospect that lithocholic acid, or molecules derived from it, could become templates for drugs treating liver diseases, metabolic syndromes, or even neurodegenerative disorders. Scientists have also started to explore its impact on receptors such as FXR and TGR5, which help regulate glucose metabolism, bile acid homeostasis, and inflammation.
Not every story about lithocholic acid shimmers with pharmaceutical promise. The molecule’s cytotoxic side poses safety hurdles. Exposure to high levels, especially among people with certain genetic defects or impaired liver function, correlates with increased risk for cholestasis and hepatic damage. Regulatory agencies keep a close eye on clinical trial protocols involving this acid, requiring rigorous toxicity testing and transparent reporting before approving any application in food or medicine.
Academics and industry chemists also discovered lithocholic acid’s value in analytical chemistry, especially when experimenting with bile acid metabolism, molecular transport, and cell signaling pathways. Creating radiolabeled analogs allows physiologists to track bile flow through animal and human bodies, a task that illuminates metabolic pathways in health and disease. Organic chemists synthesize derivatives as standard reagents and comparators when validating new synthetic or analytical methods.
I once chatted with a quality control analyst from a biomedical company about how even tiny shifts in the lot-to-lot purity of lithocholic acid impact calibration curves and downstream assays. Accurate standards make the difference between an actionable lab report and misleading data, whether the product is headed for a clinical trial or a textbook study on cholesterol metabolism.
For years, bile acids were sourced primarily by extraction from animal bile, often from cattle or pigs. Modern protocols rely more on synthetic organic chemistry, reducing the environmental footprint while addressing contamination risks or ethical controversies. With growing eco-consciousness across chemical industries, more suppliers adopt greener synthesis routes, using renewable feedstocks or biotechnological fermentation where possible.
Controversies still simmer around animal-based sourcing. I recall heated debates in academic forums over trace contaminants and how agricultural antibiotics administered to livestock could make their way into extracted bile products. Synthetically derived lithocholic acid sidesteps much of this debate, but production costs run higher, placing pressure on industrial buyers to weigh purity, price, and ethics on a single scale.
Lithocholic acid rarely makes headline news in public markets. Those in the know—medical researchers, pharmaceutical firms, analytical labs—track trends in supply, purity metrics, and regulatory outlooks with care. Price swings reflect not just availability of raw materials, but also fluctuations in reagent costs, transport logistics, and the regulatory climate.
Strong oversight from authorities like the U.S. Food and Drug Administration or its European counterparts helps maintain buyer confidence. Product labels carry batch numbers, purity measures, and certificates of analysis that document rigorous testing for heavy metals, microbiological contamination, and more. Any breach—such as a poorly documented synthetic route or a batch contaminated with solvents above safe thresholds—triggers recalls, investigations, and in some cases, public scrutiny.
Trust in lithocholic acid as a research or industrial ingredient doesn’t spring from marketing alone. It relies on transparency, reproducibility, and clear scientific documentation. Leading suppliers pursue third-party laboratory audits and share detailed analytical data, sometimes even including spectra from nuclear magnetic resonance and mass spectrometry for verification. This level of care links to real health and safety concerns, not just compliance checklists.
Anyone who’s worked with bile acids in a lab learns quickly to respect their chemical quirks. Lithocholic acid, for instance, powders easily but clumps if left exposed to room air. Ideally stored at 2-8°C, protected from light and humidity, it keeps its integrity longer when handled with clean, dry tools. Splashing a careless scoop into a beaker full of water quickly reveals why solubility matters—lithocholic acid barely dissolves, looking more like powdered chalk than a well-mixed sample.
I’ve seen colleagues struggle with solubilizing the compound for cell culture studies. Years ago, at a community lab, a team used gentle sonication and a smidge of ethanol to get the product into solution. The lesson stuck: for certain experiments, preparation isn’t a simple toss-and-stir. Even tiny changes in protocol—order of solvents, glassware cleanliness, temperature—shape the experimental outcome, influencing cell response curves and chemical reactivity.
That hands-on reality informs every practical guide and purchase decision. It’s easy to imagine researchers sitting at their workstations, comparing lithocholic acid with other choices like deoxycholic acid based on factors as simple as ease of mixing or as nuanced as cytotoxicity profiles in published literature.
Safe handling rules don’t stop at the edge of the bench. Lab managers invest in well-ventilated workspaces, chemical hoods, and personal protective equipment—gloves, goggles, and masks—when working with concentrated lithocholic acid or its solutions. The list of potential health effects runs long. Skin exposure can trigger irritation, while inhalation of airborne dust may affect respiratory health. Posters above lab sinks and storage cabinets summarize emergency response guidelines: rinse thoroughly with water, seek medical advice promptly, and keep safety data sheets close.
Outside research and industrial settings, authorities have erected strict barriers to using lithocholic acid in foods, over-the-counter supplements, or cosmetics. Part of this caution flows directly from its known health impacts at higher doses. Although some research teams dream about therapeutic breakthroughs, current law limits consumer exposure strictly to tightly monitored clinical trials or research studies with appropriate review board oversight.
Not all bile acids have the same risk-reward calculus. Cholic and ursodeoxycholic acids lead the pack in terms of general acceptance for medical therapy. Physicians prescribe ursodeoxycholic acid for certain liver diseases, confident in decades of clinical data showing both effectiveness and a relatively mild side effect profile. Cholic acid finds use in rare metabolic disorders tied to bile synthesis. In contrast, deoxycholic acid has been harnessed by the cosmetic industry to dissolve submental fat. Lithocholic acid remains mostly on the sidelines, where its research weight exceeds its commercial presence.
Peer-reviewed comparisons have confirmed that lithocholic acid displays a stronger hydrophobic character, leading to greater membrane disruption at similar concentrations. This trait limits its suitability for oral medications but opens doors for targeted therapeutics or tools in mechanistic cell biology. Scientists searching for positive controls in cytotoxicity studies, cellular stress models, or apoptosis assays find value in this compound precisely because of its razor-edge profile.
The key takeaway from years tracking this molecule is that differences in hydroxylation, solubility, and receptor affinity genuinely matter. What sets lithocholic acid apart is a blend of danger and promise: carefully controlled, it might become a linchpin in next-generation research or therapies. Mishandled, risks quickly overshadow benefits.
Lithocholic acid draws attention to the connection between fundamental science and practical application. It encourages researchers to weigh not just molecular weight or melting points but to look squarely at biological context, handling procedures, and what published evidence tells us about real-world impact. As the lines between industrial chemistry and biomedical discovery blur, buyers and users of lithocholic acid bear a responsibility to pursue rigorous data collection, transparent documentation, and open sharing of successes and failures.
Looking down the research pipeline, new applications keep appearing at the edge of possibility. Bioengineers consider modified derivatives as candidates for targeted drug delivery. Molecular biologists unravel interactions between lithocholic acid and nuclear hormone receptors, hoping to reveal larger patterns in human metabolism and disease. The growing role of artificial intelligence in drug screening adds fresh excitement: predictive models can now map thousands of potential outcomes for each bile acid, speeding up the discovery process while identifying previously overlooked risks.
Of course, not every bold idea hits pay dirt. For every published breakthrough, there are setbacks, recalls, or inconclusive data. What keeps the wheel turning is the steady interplay between those who supply lithocholic acid and those who apply it. Detailed documentation, peer review, and independent replication will continue to shape the path ahead, fostering integrity and safety alongside innovation.
The enduring relevance of lithocholic acid, with all its scientific intrigue and practical challenges, provides a solid lesson for anyone bridging the gap between chemistry and real-world impact. Each lot carries the fingerprints of synthesis, purification, and diligent handling, ready for work that may span basic metabolism studies or new clinical frontiers. Choosing the right product, understanding its context, and handling it with respect forms the core of meaningful scientific progress—a lesson embedded in every worthwhile experiment and editorial alike.